Anti-IGFBP3 antibody [EPR22152-22]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(8 Publications)
Rabbit Recombinant Monoclonal IGFBP3 antibody. Suitable for WB, IP and reacts with Mouse, Recombinant full length protein - Mouse, Rat samples. Cited in 8 publications.
View Alternative Names
Igfbp-3, Igfbp3, Insulin-like growth factor-binding protein 3, IBP-3, IGF-binding protein 3, IGFBP-3
- WB
Supplier Data
Western blot - Anti-IGFBP3 antibody [EPR22152-22] (AB220429)
Blocking and dilution buffer : 5% NFDM/TBST.
Exposure times.
Lane 1 : 8 seconds, Lane 2 : 81 seconds, Lane 3 : 3 minutes
IGFBP3 exists as both glycosylated (46 kDa) and non-glycosylated (29 kDa) form. The molecular weight observed is consistent with what has been described in the literature (PMID 10352394; PMID : 9698597; PMID 22910030).
All lanes:
Western blot - Anti-IGFBP3 antibody [EPR22152-22] (ab220429) at 1/1000 dilution
Lane 1:
Mouse lung primary cell culture supernatant at 20 µL
Lane 2:
Mouse serum at 20 µg
Lane 3:
Rat serum at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 32 kDa
Observed band size: 29 kDa,46 kDa
false
- IP
Unknown
Immunoprecipitation - Anti-IGFBP3 antibody [EPR22152-22] (AB220429)
IGFBP3 was immunoprecipitated from 0.35 mg of rat serum with ab220429 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab220429 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/5000 dilution.
Lane 1 : Rat serum 10 μg (Input).
Lane 2 : ab220429 IP in rat serum (+).
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab20429 in rat serum.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 30 seconds.
Both glycosylated (46 kDa) and non-glycosylated (29 kDa) IGFBP-3 are detected in rat serum. The molecular weight observed is consistent with what has been described in the literature (PMID 10352394; PMID : 9698597).
All lanes:
Immunoprecipitation - Anti-IGFBP3 antibody [EPR22152-22] (ab220429)
Predicted band size: 32 kDa
Observed band size: 29 kDa,46 kDa
false
- IP
Unknown
Immunoprecipitation - Anti-IGFBP3 antibody [EPR22152-22] (AB220429)
IGFBP3 was immunoprecipitated from 0.35 mg of mouse serum with ab220429 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab220429 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/5000 dilution.
Lane 1 : Mouse serum 10 μg (Input).
Lane 2 : ab220429 IP in mouse serum (+).
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab20429 in mouse serum.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 30 seconds.
Non-glycosylated IGFBP-3 (29 kDa) is detected in mouse serum. The molecular weight observed is consistent with what has been described in the literature (PMID 10352394).
All lanes:
Immunoprecipitation - Anti-IGFBP3 antibody [EPR22152-22] (ab220429)
Predicted band size: 32 kDa
Observed band size: 29 kDa
false
- WB
Supplier Data
Western blot - Anti-IGFBP3 antibody [EPR22152-22] (AB220429)
Blocking and dilution buffer : 5% NFDM/TBST.
The recombinant fragment was expressed in a mammalian expression system.
All lanes:
Western blot - Anti-IGFBP3 antibody [EPR22152-22] (ab220429) at 1/1000 dilution
All lanes:
Mouse IGFBP3 recombinant protein (aa22-291) at 0.02 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 32 kDa
Observed band size: 29 kDa,46 kDa
false
Exposure time: 3s
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (8)
Recent publications for all applications. Explore the full list and refine your search
Journal of translational internal medicine 13:281-294 PubMed40896287
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 16:1590096 PubMed40406492
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell biology and toxicology 41:85 PubMed40369223
2025
Applications
Unspecified application
Species
Unspecified reactive species
European journal of medical research 30:144 PubMed40022250
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nutrients 16: PubMed38674874
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular medicine 50: PubMed35929517
2022
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 22:1114 PubMed34504568
2021
Applications
Unspecified application
Species
Unspecified reactive species
Advances in clinical and experimental medicine : official organ Wroclaw Medical University 30:661-672 PubMed34118139
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com